American Century Companies Inc. raised its position in shares of Teleflex Incorporated (NYSE:TFX) by 22.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 839,080 shares of the medical technology company’s stock after buying an additional 155,863 shares during the period. American Century Companies Inc. owned approximately 1.87% of Teleflex worth $174,327,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Teachers Advisors LLC increased its position in shares of Teleflex by 4.8% in the fourth quarter. Teachers Advisors LLC now owns 45,560 shares of the medical technology company’s stock worth $7,342,000 after buying an additional 2,074 shares during the last quarter. Huntington National Bank increased its position in shares of Teleflex by 573.3% in the first quarter. Huntington National Bank now owns 2,316 shares of the medical technology company’s stock worth $449,000 after buying an additional 1,972 shares during the last quarter. Mn Services Vermogensbeheer B.V. increased its position in shares of Teleflex by 3.1% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 1,175 shares of the medical technology company’s stock worth $213,000 after buying an additional 35 shares during the last quarter. Profund Advisors LLC increased its position in shares of Teleflex by 6.1% in the first quarter. Profund Advisors LLC now owns 7,614 shares of the medical technology company’s stock worth $1,475,000 after buying an additional 438 shares during the last quarter. Finally, Sit Investment Associates Inc. increased its position in shares of Teleflex by 180.0% in the first quarter. Sit Investment Associates Inc. now owns 2,800 shares of the medical technology company’s stock worth $542,000 after buying an additional 1,800 shares during the last quarter. 92.59% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Incorporated (NYSE TFX) opened at 207.01 on Friday. The company has a market cap of $9.32 billion, a P/E ratio of 39.59 and a beta of 1.05. Teleflex Incorporated has a 12-month low of $136.53 and a 12-month high of $217.97. The firm has a 50-day moving average price of $210.33 and a 200-day moving average price of $199.98.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.91 by $0.13. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The firm had revenue of $528.60 million for the quarter, compared to analyst estimates of $518.98 million. During the same quarter last year, the company posted $1.89 earnings per share. The business’s revenue was up 11.6% on a year-over-year basis. On average, analysts forecast that Teleflex Incorporated will post $8.28 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, September 15th. Investors of record on Tuesday, August 15th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date of this dividend is Friday, August 11th. Teleflex’s dividend payout ratio is currently 26.00%.

TRADEMARK VIOLATION NOTICE: This news story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/08/26/teleflex-incorporated-tfx-shares-bought-by-american-century-companies-inc.html.

A number of research analysts have recently issued reports on TFX shares. Needham & Company LLC reaffirmed a “buy” rating and set a $224.00 price target on shares of Teleflex in a report on Friday, May 5th. Deutsche Bank AG increased their target price on Teleflex from $213.00 to $220.00 and gave the company a “buy” rating in a report on Monday, May 8th. Zacks Investment Research downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, May 20th. Leerink Swann increased their target price on Teleflex from $215.00 to $220.00 and gave the company a “market perform” rating in a report on Friday, June 9th. Finally, Barclays PLC reissued a “buy” rating on shares of Teleflex in a report on Monday, June 26th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $228.83.

In related news, Director Stuart A. Randle sold 2,500 shares of the firm’s stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $205.67, for a total transaction of $514,175.00. Following the transaction, the director now owns 7,532 shares of the company’s stock, valued at $1,549,106.44. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of the firm’s stock in a transaction dated Tuesday, August 1st. The stock was sold at an average price of $208.41, for a total value of $41,682.00. Following the transaction, the director now directly owns 8,080 shares in the company, valued at approximately $1,683,952.80. The disclosure for this sale can be found here. In the last three months, insiders have sold 3,100 shares of company stock worth $637,463. Corporate insiders own 2.39% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Stock Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related stocks with our FREE daily email newsletter.